Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/05/2009US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009US20090274652 Hepatitis C Virus Inhibitors
11/05/2009US20090274651 Therapeutic agent for infections, and treatment method using the same
11/05/2009US20090274650 Inhibitors of aspartyl protease
11/05/2009US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009US20090274648 Hepatitis c virus inhibitors
11/05/2009US20090274647 Immunotherapeutic Formulations with Interleukin-2-Neutralizing Capacity
11/05/2009US20090274635 Bactericide having selectivity to cariogenic bacterium, and a method for sterilization of cariogenic bacterium
11/05/2009US20090274626 TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
11/05/2009US20090274625 Compositions and Methods for The Treatment of Cancer
11/05/2009US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009CA2725128A1 Neurotrophic factor manf and uses thereof
11/05/2009CA2723276A1 Fgf-9 and its use relating to blood vessels
11/05/2009CA2723169A1 Substances and compositions for enhancing dna repair and methods of use
11/05/2009CA2723143A1 Methods and compositions for prostate cancer immunotherapy
11/05/2009CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009CA2722854A1 Restoration of estrogen receptor-.alpha. activity
11/05/2009CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009CA2722671A1 Use of nucleic acids with reduced pressure therapy
11/05/2009CA2722668A1 Methods for treating inflammation
11/05/2009CA2722628A1 Super fast-acting insulin compositions
11/05/2009CA2722426A1 Methods of using corticotropin-releasing factor for the treatment of cancer
11/05/2009CA2721982A1 Assay for pathogenic conformers
11/05/2009CA2704446A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses
11/05/2009CA2630510A1 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/04/2009EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009EP2113517A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
11/04/2009EP2113514A1 Method for creating hypoallergenic glycoproteins in mutated or genetically modified plants or plant cells and mutated or genetically modified plants and plant cells for creating hypoallergenic glycoproteins
11/04/2009EP2113513A2 Metastin derivatives and use thereof
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2113257A1 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/04/2009EP2113254A1 Compositions for treating an inflammatory auto-immune condition
11/04/2009EP2113253A1 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
11/04/2009EP2112999A1 Non-natural recombinant gelatins with enhanced functionality
11/04/2009EP2112998A1 Rgd containing recombinant gelatin
11/04/2009EP2112997A1 Recombinant xrgd-enriched gelatins having high stability
11/04/2009EP2112930A2 Modulation of nkt cell activity with antigen-loaded cdid molecules
11/04/2009EP1692180B1 Anti-il-20 antibodies and binding partners and methods of using in inflammation
11/04/2009EP1682180B1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
11/04/2009EP1680150B1 Composite material containing hydrogen, produced by the electrically-triggered precipitation of a solid phase
11/04/2009EP1620131B1 Ghrh for use in treating chronic renal failure
11/04/2009EP1559721B1 Fprl1 ligands and use thereof
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1261623B1 New retinol derivatives, the method of preparations and the uses thereof
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009EP1098910B1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
11/04/2009EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/04/2009CN101573376A Selective glucagon-like-peptide-2 (GLP-2) analogues
11/04/2009CN101573133A PEGylated, extended insulins
11/04/2009CN101573131A Anti-connexin compounds and uses thereof
11/03/2009US7612192 Neisseria genomic sequences and methods of their use
11/03/2009US7612188 Modified vitamin K. dependent polypeptides
11/03/2009US7612176 Polymer-based sustained release device
11/03/2009US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009US7612174 Scavenger receptor
11/03/2009US7612172 Immunization; used to elicit a humoral or cellular immune response
11/03/2009US7612171 DB, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/03/2009US7612170 Co-stimulatory polypeptides
11/03/2009US7612169 Demonstrate reduced binding affinity for TNF-related apoptosis inducing ligand (TRAIL) ; bone disorders; osteoporosis, hypercalcemia, Paget's disease of bone, multiple myeloma, bone cancer and bone loss due to rheumatoid arthritis or osteomyelitis
11/03/2009US7612166 Fluorous capping reagents and methods for peptide purification
11/03/2009US7612165 Solid-phase synthesis is a capillary
11/03/2009US7612164 Cardiac muscle function and manipulation
11/03/2009US7612163 Prokineticin 2β peptide and its use
11/03/2009US7612162 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
11/03/2009US7612058 Administering 1-(4-fluorophenyl)-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl)]-4(S)-[4-(phenylmethoxy)phenyl]-2-azetidinone; and peroxisome proliferator-activated receptor activator; obesity, antidiabetic agents
11/03/2009US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans
11/03/2009US7612046 Administering a substance capable of inducing and/or enhancing Pax2 expression.
11/03/2009US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009US7612043 Integrins; interleukins; antifertility agents
11/03/2009US7612042 Using soluble isoform of estrogen receptor as heregulin inhibiting therapeutic for use in treatment and prevention of breast and prostate cancer; competitive binding; gene therapy
11/03/2009US7612041 Osteoporosis; transforming growth factors; pyrogen-free
11/03/2009US7612040 Lefty polypeptides and derivatives thereof
11/03/2009US7612039 From polyoma virus; replication-defective
11/03/2009US7612038 Stabilizing dystrophin associated protein complexes; abnormal synapses or neuromuscular junction disorders
11/03/2009US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009US7612035 Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
11/03/2009US7612034 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
11/03/2009US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009US7612032 Parenterally injecting bovine pancreatic DNAse to destroy extracellular DNA in systemic blood circulation of cancer patient slow down malignancy; treating lung carcinomas
11/03/2009US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009US7611879 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders
11/03/2009US7611868 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system
11/03/2009US7611867 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/03/2009US7611865 Genetic engineering
11/03/2009US7611864 Proinsulin polypeptide-oligomer conjugates
11/03/2009US7611857 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
11/03/2009US7611846 Diagnostic methods involving human growth factor huXAG-1
11/03/2009US7611833 Comprising an altered MAB1, MAB2, MAB3, or OLE1 gene; evaluating a substance as a positive strand RNA antiviral agent
11/03/2009US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009US7611830 Device to lavage a blood vessel
11/03/2009US7611724 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
11/03/2009US7611721 Adjuvant combination formulations
11/03/2009US7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositions
11/03/2009US7611711 VEGFR-3 inhibitor materials and methods
11/03/2009US7611702 TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/03/2009US7611701 Generation of granulate for use in animal feeds; prepare enzyme, water and solid support, recover granules and dry
11/03/2009US7611700 Enyme resistant stimulatory protein for use as tools in treatment and prevention of viral infections, cell proliferative and autoimmune disorders
11/03/2009US7611699 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention;
1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 3163